SFMG Wealth Advisors’s Alaunos Therapeutics TCRT Stock Holding History

SFMG Wealth Advisors’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-416	Closed	-$225K	–	276
2021 Q1	$225K	Hold	416	–	–	0.03%	216
2020 Q4	$157K	Hold	416	–	–	0.02%	216
2020 Q3	$157K	Hold	416	–	–	0.02%	173
2020 Q2	$205K	Hold	416	–	–	0.03%	151
2020 Q1	$153K	Hold	416	–	–	0.02%	129
2019 Q4	$295K	Hold	416	–	–	0.04%	128
2019 Q3	$267K	Hold	416	–	–	0.04%	123
2019 Q2	$386K	Hold	416	–	–	0.05%	105
2019 Q1	$240K	Hold	416	–	–	0.03%	125
2018 Q4	$117K	Hold	416	–	–	0.02%	133
2018 Q3	$148K	Hold	416	–	–	0.02%	137
2018 Q2	$189K	Sell	416 -7	-2%	-$4.44K	0.03%	146
2018 Q1	$249K	Buy	423 +7	+2%	+$4.36K	0.04%	118
2017 Q4	$258K	Hold	416	–	–	0.04%	116
2017 Q3	$383K	Hold	416	–	–	0.07%	83
2017 Q2	$388K	Hold	416	–	–	0.08%	73
2017 Q1	$396K	Hold	416	–	–	0.08%	70
2016 Q4	$334K	Hold	416	–	–	0.07%	78
2016 Q3	$351K	Hold	416	–	–	0.08%	75
2016 Q2	$343K	Hold	416	–	–	0.08%	78
2016 Q1	$463K	Hold	416	–	–	0.1%	64
2015 Q4	$519K	Hold	416	–	–	0.12%	74
2015 Q3	$563K	Hold	416	–	–	0.14%	68
2015 Q2	$749K	Sell	416 -416	-50%	-$646K	0.17%	64
2015 Q1	$1.34M	Buy	832 +166	+25%	+$246K	0.11%	68
2014 Q4	$506K	Hold	666	–	–	0.11%	79
2014 Q3	$264K	Hold	666	–	–	0.08%	64
2014 Q2	$402K	Hold	666	–	–	0.14%	48
2014 Q1	$457K	Hold	666	–	–	0.15%	41
2013 Q4	$433K	Hold	666	–	–	0.15%	43
2013 Q3	$393K	Hold	666	–	–	0.16%	43
2013 Q2	$211K	Buy	+666	New	+$185K	0.08%	61

Other funds holding TCRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

SFMG Wealth Advisors's TCRT Position: Q2 2021 in Review

SFMG Wealth Advisors sold out of Alaunos Therapeutics (TCRT) in Q2 2021, closing a stake of 416 shares — an estimated $225K sold.

SFMG Wealth Advisors first reported a position in TCRT in Q2 2013 and held it in 32 quarters. The position peaked at $1.34M in Q1 2015. 155 funds tracked by Wall St. Rank hold TCRT as of Q2 2021.

SFMG Wealth Advisors reported no remaining Alaunos Therapeutics position as of Q2 2021 after selling out during the quarter.
SFMG Wealth Advisors sold 416 Alaunos Therapeutics shares in Q2 2021, an estimated $225K.
SFMG Wealth Advisors first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 32 quarters.
SFMG Wealth Advisors's Alaunos Therapeutics position peaked at $1.34M in Q1 2015.
155 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2021.

Based on SFMG Wealth Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.